Medtronic Q4 Organic Revenue Beat Driven by Cardiovascular, Medical Surgical Strength, Truist Says

MT Newswires Live06-04

Medtronic (MDT) reported fiscal Q4 organic revenue growth ahead of expectations amid strength in its Cardiovascular and Medical Surgical businesses, Truist Securities said in a note Wednesday.

The brokerage said Medtronic posted 6.5% organic revenue growth excluding Diabetes and Other that topped consensus estimates. Cardiovascular and Medical Surgical revenue exceeded expectations.

Truist noted that gross margin and operating margin were below expectations and elevated selling, general and administrative expenses weighed on profitability. Adjusted earnings per share of $1.55 exceeded estimates by $0.01 due to foreign exchange and non-operating items, according to the note.

The brokerage said Medtronic's fiscal 2027 guidance for 6.75% to 7.25% organic revenue growth is broadly in line with expectations after adjusting for the benefit of an extra selling week.

Guidance includes contributions from the Diabetes business, incorporates about $250 million of tariff-related costs, and does not assume any benefit from share repurchases related to the planned Diabetes spin-off.

Truist maintained its hold rating and $95 price target on Medtronic.

Shares of Medtronic were up 5.5% in Wednesday trading.

Price: 77.79, Change: +4.04, Percent Change: +5.48

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2640899491?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-06-04 03:39","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2640899491","market":"fut","top_or_hot":-1,"title":"Medtronic Q4 Organic Revenue Beat Driven by Cardiovascular, Medical Surgical Strength, Truist Says","media":"MT Newswires Live","content":"<html><body><p> Medtronic (MDT) reported fiscal Q4 organic revenue growth ahead of expectations amid strength in its Cardiovascular and Medical Surgical businesses, Truist Securities said in a note Wednesday.</p><p>The brokerage said Medtronic posted 6.5% organic revenue growth excluding Diabetes and Other that topped consensus estimates. Cardiovascular and Medical Surgical revenue exceeded expectations.</p><p>Truist noted that gross margin and operating margin were below expectations and elevated selling, general and administrative expenses weighed on profitability. Adjusted earnings per share of $1.55 exceeded estimates by $0.01 due to foreign exchange and non-operating items, according to the note.</p><p>The brokerage said Medtronic's fiscal 2027 guidance for 6.75% to 7.25% organic revenue growth is broadly in line with expectations after adjusting for the benefit of an extra selling week.</p><p>Guidance includes contributions from the Diabetes business, incorporates about $250 million of tariff-related costs, and does not assume any benefit from share repurchases related to the planned Diabetes spin-off.</p><p>Truist maintained its hold rating and $95 price target on Medtronic.</p><p>Shares of Medtronic were up 5.5% in Wednesday trading.</p><p>Price: 77.79, Change: +4.04, Percent Change: +5.48</p></body></html>","source":"mtnewswires_news","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Medtronic Q4 Organic Revenue Beat Driven by Cardiovascular, Medical Surgical Strength, Truist Says</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nMedtronic Q4 Organic Revenue Beat Driven by Cardiovascular, Medical Surgical Strength, Truist Says\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1092851196\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">MT Newswires Live </p>\n<p class=\"h-time\">2026-06-04 03:39</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html><body><p> Medtronic (MDT) reported fiscal Q4 organic revenue growth ahead of expectations amid strength in its Cardiovascular and Medical Surgical businesses, Truist Securities said in a note Wednesday.</p><p>The brokerage said Medtronic posted 6.5% organic revenue growth excluding Diabetes and Other that topped consensus estimates. Cardiovascular and Medical Surgical revenue exceeded expectations.</p><p>Truist noted that gross margin and operating margin were below expectations and elevated selling, general and administrative expenses weighed on profitability. Adjusted earnings per share of $1.55 exceeded estimates by $0.01 due to foreign exchange and non-operating items, according to the note.</p><p>The brokerage said Medtronic's fiscal 2027 guidance for 6.75% to 7.25% organic revenue growth is broadly in line with expectations after adjusting for the benefit of an extra selling week.</p><p>Guidance includes contributions from the Diabetes business, incorporates about $250 million of tariff-related costs, and does not assume any benefit from share repurchases related to the planned Diabetes spin-off.</p><p>Truist maintained its hold rating and $95 price target on Medtronic.</p><p>Shares of Medtronic were up 5.5% in Wednesday trading.</p><p>Price: 77.79, Change: +4.04, Percent Change: +5.48</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"CSII","symbol_name":"Cardiovascular Systems","start_time":0,"source_url":"https://www.mtnewswires.com/","article_id":"2640899491","we_media_id":"1092851196","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2640899491","pubTimestamp":1780515551,"columns":[],"sourceInfo":{"source_id":"mtnewswires_news","name":"MT Newswires"},"weMediaInfo":{"media_name":"MT Newswires Live","introduction":"The most recognized names in North America, Europe and Asia rely on MT Newswires to power their applications. Better news, better service, better price.","home_visible":1,"id":"1092851196","head_image":"https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e"},"summary":"Medtronic (MDT) reported fiscal Q4 organic revenue growth ahead of expectations amid strength in its Cardiovascular and Medical Surgical businesses, Truist Securities said in a note Wednesday.The brok","collect":0,"end_time":0,"defaultTopTitle":"","property":["earning"],"viewcount":null,"language":"en","relate_stocks":{"CSII":"Cardiovascular Systems"},"translate_title":"Truist表示，美敦力第四季度有机收入增长得益于心血管和医疗外科实力","themeId":"f6f7c9f6a0174df79daf9f1dfd21f836","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"CSII":1.5},"content_text":"Medtronic (MDT) reported fiscal Q4 organic revenue growth ahead of expectations amid strength in its Cardiovascular and Medical Surgical businesses, Truist Securities said in a note Wednesday.The brokerage said Medtronic posted 6.5% organic revenue growth excluding Diabetes and Other that topped consensus estimates. Cardiovascular and Medical Surgical revenue exceeded expectations.Truist noted that gross margin and operating margin were below expectations and elevated selling, general and administrative expenses weighed on profitability. Adjusted earnings per share of $1.55 exceeded estimates by $0.01 due to foreign exchange and non-operating items, according to the note.The brokerage said Medtronic's fiscal 2027 guidance for 6.75% to 7.25% organic revenue growth is broadly in line with expectations after adjusting for the benefit of an extra selling week.Guidance includes contributions from the Diabetes business, incorporates about $250 million of tariff-related costs, and does not assume any benefit from share repurchases related to the planned Diabetes spin-off.Truist maintained its hold rating and $95 price target on Medtronic.Shares of Medtronic were up 5.5% in Wednesday trading.Price: 77.79, Change: +4.04, Percent Change: +5.48","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"dataReport","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.44.0","shortVersion":"4.44.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2640899491","isCrawlerRequest":true}